Mastercard and Ally Ventures co-led a round which will support the credit card services provider's expansion, boosting its total funding to over $140m.

DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Sanofi Ventures co-led replacement therapy developer Glycomine's latest round, which included Novo, Asahi Kasei Pharma Ventures and Chiesi Ventures.

Alexandria Venture Investments backed precision immunology therapeutics developer ImmuneID in the round, which was led by venture capital firm Alta Partners.

Sheng Ye Capital and existing investor So-Young participated in a round for the medical supplies ordering platform sized at a minimum of $70m.

Eli Lilly, Johnson & Johnson and Pfizer helped drug developer TRexBio close its $59m series A round while Slack backed human resources software provider Oyster at a $475m valuation.

Matrix Partners China and Citic Private Equity Funds Management co-led the series B round, which will fund development of treatments for rare medical conditions.

Morgan Stanley, NTT Data, Sumitomo Mitsui Trust Bank, Ripple, Ripio and Mouro Capital helped the tokenisation technology provider take its total funding to over $74m.

Maersk Growth and Raed Ventures co-led a $42m round for shipping platform developer Trella while GV exited deep learning software provider Determined AI.